US Stock MarketDetailed Quotes

ATAI ATAI Life Sciences

Watchlist
  • 1.110
  • +0.030+2.78%
Trading Nov 4 14:23 ET
186.26MMarket Cap-3083P/E (TTM)

ATAI Life Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
28.24%-16.23M
-6.93%-22.57M
19.48%-84.12M
28.01%-21.96M
34.28%-18.43M
-3.11%-22.61M
11.99%-21.11M
-65.18%-104.47M
-48.74%-30.51M
0.23%-28.05M
Net income from continuing operations
-69.87%-57.37M
20.31%-27.38M
72.12%-43.9M
58.97%-19.14M
221.49%43.37M
9.96%-33.77M
8.53%-34.35M
9.66%-157.42M
49.99%-46.65M
-12.83%-35.7M
Operating gains losses
-93.47%126K
1.61%1.9M
-54.74%4.33M
-87.10%578K
98.03%-42K
-38.62%1.93M
-54.26%1.87M
-64.27%9.57M
-90.27%4.48M
38.08%-2.13M
Depreciation and amortization
3.80%82K
27.69%83K
89.88%319K
90.57%101K
105.56%74K
315.79%79K
8.33%65K
257.45%168K
82.76%53K
614.29%36K
Deferred tax
----
----
--0
----
----
----
----
--5.07M
----
----
Other non cash items
7,239.55%31.77M
306.24%2.08M
-4,816.63%-86.34M
-5,969.09%-86.79M
519.82%1.91M
-336.70%-445K
-1,581.67%-1.01M
-110.94%-1.76M
-123.12%-1.43M
2.58%-454K
Change In working capital
246.57%2.88M
-236.99%-5.01M
323.96%7.47M
165.19%2.64M
902.94%341K
-60.97%831K
351.89%3.66M
56.14%-3.34M
-1,555.04%-4.05M
100.70%34K
-Change in prepaid assets
-63.04%1.08M
-99.71%14K
669.19%8.66M
660.55%1.95M
60.18%-1.08M
31.28%2.93M
478.04%4.87M
84.31%-1.52M
709.52%256K
65.97%-2.72M
-Change in payables and accrued expense
185.91%1.8M
-314.51%-5.03M
34.14%-1.19M
116.04%690K
-48.27%1.42M
-2,015.15%-2.09M
-639.63%-1.21M
-122.50%-1.81M
-166.57%-4.3M
-10.13%2.75M
Cash from discontinued investing activities
Operating cash flow
28.24%-16.23M
-6.93%-22.57M
19.48%-84.12M
28.01%-21.96M
34.28%-18.43M
-3.11%-22.61M
11.99%-21.11M
-65.18%-104.47M
-48.74%-30.51M
0.23%-28.05M
Investing cash flow
Cash flow from continuing investing activities
174.07%16.3M
-28.38%11.47M
38.63%-53.3M
-101.03%-824K
-170.38%-46.49M
-20.81%-22.01M
107.46%16.02M
-6.86%-86.85M
264.60%80.05M
10,857.33%66.05M
Capital expenditure reported
--0
96.93%-5K
-31.87%-331K
88.89%-9K
97.14%-2K
-57.00%-157K
---163K
73.72%-251K
73.44%-81K
85.86%-70K
Net PPE purchase and sale
--0
--0
66.49%-259K
94.37%-8K
--0
125.00%29K
-400.00%-280K
-346.82%-773K
-173.08%-142K
-359.32%-459K
Net business purchase and sale
----
----
---443K
--37K
----
----
----
--0
--0
----
Net investment purchase and sale
187.83%19.22M
-35.89%12.48M
43.56%-46.75M
-99.78%173K
-166.85%-44.51M
-21.55%-21.88M
109.19%19.46M
-250.09%-82.82M
8,027,400.00%80.28M
31,211.68%66.58M
Net other investing changes
---2.91M
66.63%-1M
-83.77%-5.51M
---1.02M
---1.5M
--0
0.00%-3M
15.56%-3M
--0
--0
Cash from discontinued investing activities
Investing cash flow
174.08%16.3M
-28.39%11.47M
38.63%-53.3M
-101.03%-823K
-170.38%-46.49M
-20.81%-22.01M
107.46%16.02M
-6.86%-86.85M
264.60%80.05M
10,857.33%66.05M
Financing cash flow
Cash flow from continuing financing activities
426.00%326K
0
-140.20%-8.36M
-817.68%-8.46M
0
-105.57%-100K
56.06%206K
-94.93%20.79M
-153.51%-922K
410.21%19.78M
Net issuance payments of debt
----
----
--0
--0
----
----
----
844.58%15M
--0
----
Net preferred stock issuance
----
----
--0
--0
----
----
----
--600K
--0
--0
Proceeds from stock option exercised by employees
--326K
--0
-91.06%205K
-100.81%-1K
--0
--0
56.06%206K
56.16%2.29M
-86.84%123K
--1.92M
Net other financing activities
----
----
-396.09%-8.56M
-709.57%-8.46M
--0
----
----
193.89%2.89M
-232.78%-1.05M
----
Cash from discontinued financing activities
Financing cash flow
426.00%326K
--0
-140.20%-8.36M
-817.68%-8.46M
--0
-105.57%-100K
56.06%206K
-94.93%20.79M
-153.51%-922K
410.21%19.78M
Net cash flow
Beginning cash position
-81.78%33.87M
-76.37%45.03M
-47.38%190.61M
-46.34%76.49M
67.70%141.09M
49.94%185.89M
-47.38%190.61M
272.53%362.27M
-66.88%142.54M
-81.45%84.13M
Current changes in cash
100.89%400K
-127.19%-11.1M
14.52%-145.77M
-164.26%-31.25M
-212.34%-64.92M
-16.60%-44.72M
97.95%-4.89M
-164.27%-170.53M
172.12%48.63M
332.57%57.79M
Effect of exchange rate changes
186.84%66K
-140.25%-64K
116.83%189K
61.52%-212K
-48.79%318K
94.91%-76K
-46.82%159K
-250.94%-1.12M
11.56%-551K
-59.49%621K
End cash Position
-75.67%34.33M
-81.78%33.87M
-76.37%45.03M
-76.37%45.03M
-46.34%76.49M
67.70%141.09M
49.94%185.89M
-47.38%190.61M
-47.38%190.61M
-66.88%142.54M
Free cash flow
28.64%-16.23M
-4.75%-22.58M
19.70%-84.71M
28.47%-21.98M
35.49%-18.43M
-2.69%-22.74M
10.35%-21.55M
-63.87%-105.49M
-47.26%-30.73M
-0.51%-28.57M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 28.24%-16.23M-6.93%-22.57M19.48%-84.12M28.01%-21.96M34.28%-18.43M-3.11%-22.61M11.99%-21.11M-65.18%-104.47M-48.74%-30.51M0.23%-28.05M
Net income from continuing operations -69.87%-57.37M20.31%-27.38M72.12%-43.9M58.97%-19.14M221.49%43.37M9.96%-33.77M8.53%-34.35M9.66%-157.42M49.99%-46.65M-12.83%-35.7M
Operating gains losses -93.47%126K1.61%1.9M-54.74%4.33M-87.10%578K98.03%-42K-38.62%1.93M-54.26%1.87M-64.27%9.57M-90.27%4.48M38.08%-2.13M
Depreciation and amortization 3.80%82K27.69%83K89.88%319K90.57%101K105.56%74K315.79%79K8.33%65K257.45%168K82.76%53K614.29%36K
Deferred tax ----------0------------------5.07M--------
Other non cash items 7,239.55%31.77M306.24%2.08M-4,816.63%-86.34M-5,969.09%-86.79M519.82%1.91M-336.70%-445K-1,581.67%-1.01M-110.94%-1.76M-123.12%-1.43M2.58%-454K
Change In working capital 246.57%2.88M-236.99%-5.01M323.96%7.47M165.19%2.64M902.94%341K-60.97%831K351.89%3.66M56.14%-3.34M-1,555.04%-4.05M100.70%34K
-Change in prepaid assets -63.04%1.08M-99.71%14K669.19%8.66M660.55%1.95M60.18%-1.08M31.28%2.93M478.04%4.87M84.31%-1.52M709.52%256K65.97%-2.72M
-Change in payables and accrued expense 185.91%1.8M-314.51%-5.03M34.14%-1.19M116.04%690K-48.27%1.42M-2,015.15%-2.09M-639.63%-1.21M-122.50%-1.81M-166.57%-4.3M-10.13%2.75M
Cash from discontinued investing activities
Operating cash flow 28.24%-16.23M-6.93%-22.57M19.48%-84.12M28.01%-21.96M34.28%-18.43M-3.11%-22.61M11.99%-21.11M-65.18%-104.47M-48.74%-30.51M0.23%-28.05M
Investing cash flow
Cash flow from continuing investing activities 174.07%16.3M-28.38%11.47M38.63%-53.3M-101.03%-824K-170.38%-46.49M-20.81%-22.01M107.46%16.02M-6.86%-86.85M264.60%80.05M10,857.33%66.05M
Capital expenditure reported --096.93%-5K-31.87%-331K88.89%-9K97.14%-2K-57.00%-157K---163K73.72%-251K73.44%-81K85.86%-70K
Net PPE purchase and sale --0--066.49%-259K94.37%-8K--0125.00%29K-400.00%-280K-346.82%-773K-173.08%-142K-359.32%-459K
Net business purchase and sale -----------443K--37K--------------0--0----
Net investment purchase and sale 187.83%19.22M-35.89%12.48M43.56%-46.75M-99.78%173K-166.85%-44.51M-21.55%-21.88M109.19%19.46M-250.09%-82.82M8,027,400.00%80.28M31,211.68%66.58M
Net other investing changes ---2.91M66.63%-1M-83.77%-5.51M---1.02M---1.5M--00.00%-3M15.56%-3M--0--0
Cash from discontinued investing activities
Investing cash flow 174.08%16.3M-28.39%11.47M38.63%-53.3M-101.03%-823K-170.38%-46.49M-20.81%-22.01M107.46%16.02M-6.86%-86.85M264.60%80.05M10,857.33%66.05M
Financing cash flow
Cash flow from continuing financing activities 426.00%326K0-140.20%-8.36M-817.68%-8.46M0-105.57%-100K56.06%206K-94.93%20.79M-153.51%-922K410.21%19.78M
Net issuance payments of debt ----------0--0------------844.58%15M--0----
Net preferred stock issuance ----------0--0--------------600K--0--0
Proceeds from stock option exercised by employees --326K--0-91.06%205K-100.81%-1K--0--056.06%206K56.16%2.29M-86.84%123K--1.92M
Net other financing activities ---------396.09%-8.56M-709.57%-8.46M--0--------193.89%2.89M-232.78%-1.05M----
Cash from discontinued financing activities
Financing cash flow 426.00%326K--0-140.20%-8.36M-817.68%-8.46M--0-105.57%-100K56.06%206K-94.93%20.79M-153.51%-922K410.21%19.78M
Net cash flow
Beginning cash position -81.78%33.87M-76.37%45.03M-47.38%190.61M-46.34%76.49M67.70%141.09M49.94%185.89M-47.38%190.61M272.53%362.27M-66.88%142.54M-81.45%84.13M
Current changes in cash 100.89%400K-127.19%-11.1M14.52%-145.77M-164.26%-31.25M-212.34%-64.92M-16.60%-44.72M97.95%-4.89M-164.27%-170.53M172.12%48.63M332.57%57.79M
Effect of exchange rate changes 186.84%66K-140.25%-64K116.83%189K61.52%-212K-48.79%318K94.91%-76K-46.82%159K-250.94%-1.12M11.56%-551K-59.49%621K
End cash Position -75.67%34.33M-81.78%33.87M-76.37%45.03M-76.37%45.03M-46.34%76.49M67.70%141.09M49.94%185.89M-47.38%190.61M-47.38%190.61M-66.88%142.54M
Free cash flow 28.64%-16.23M-4.75%-22.58M19.70%-84.71M28.47%-21.98M35.49%-18.43M-2.69%-22.74M10.35%-21.55M-63.87%-105.49M-47.26%-30.73M-0.51%-28.57M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data